| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $4.92B | -0.2% |
| Cost of Revenue | $2.87B | +3.6% |
| Gross Profit | $2.05B | -5.1% |
| R&D Expense | $29.2M | +7.0% |
| SG&A Expense | $992.5M | +7.5% |
| Operating Income | $680.6M | -25.4% |
| Interest Expense | $103.0M | +55.4% |
| Pre-tax Income | $577.2M | -30.0% |
| Income Tax | $119.0M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $69.4M | -76.9% |
| Accounts Receivable | $422.6M | +0.7% |
| Inventory | $555.0M | +19.6% |
| Current Assets | $1.20B | -6.3% |
| Total Assets | $4.36B | +0.8% |
| Current Liabilities | $981.2M | -6.9% |
| Long-term Debt | $2.75B | +20.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $378.8M | -47.6% |
| Capital Expenditures | $306.5M | +148.6% |
| Investing Cash Flow | -$315.3M | +43.2% |
| Financing Cash Flow | -$279.1M | -464.8% |
| Free Cash Flow | $72.3M | -87.9% |
| -40.0% |
| Net Income | $455.7M | -27.0% |
| EPS (Basic) | $2.61 | -17.7% |
| EPS (Diluted) | $2.53 | -17.3% |
| Total Liabilities |
| $4.37B |
| +8.5% |
| Stockholders' Equity | -$22.1M | -107.7% |